Risk factors for tumor enlargement in low-risk papillary thyroid microcarcinoma patients: a systematic review and meta-analysis
- 10 April 2024
- journal article
- review article
- Published by Springer Nature in Endocrine
- Vol. 85 (3) , 1-9
Abstract
Purpose The current management guidelines for low-risk papillary thyroid microcarcinoma (PTMC) do not specify how to screen for growing tumors. We sought to explore the possible risk factors for tumor enlargement in patients with low-risk PTMC under active surveillance (AS). Methods We searched the PubMed and Embase databases for high quality studies up to January 10th, 2024. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of the included studies, and Review Manager 5.4 was used to analyze possible risk factors and calculate pooled risk ratios (RRs) via the inverse-variance calculation method. Results Eleven studies were included in our meta-analysis. Among the 8880 participants, 464 experienced tumor growth, and the incidence of tumor growth varied from 3.4% to 19.4%. The results of the meta-analysis showed that tumor enlargement was associated with younger age (pooled RR = 2.32, 95% CI = 1.85–2.90, p < 0.00001; 8 studies), and higher serum thyroid-stimulating hormone (TSH) levels (pooled RR = 2.28, 95% CI = 1.19–4.37, p = 0.01; 6 studies), and could be related to pregnancy (pooled RR = 2.54, 95% CI = 1.17–5.52, p = 0.02; 2 studies). However, these following factors showed no significant association with tumor growth: sex (pooled RR = 1.07, 95% CI = 0.63–1.84, p = 0.79; 7 studies), tumor size at diagnosis (pooled RR = 1.08, 95% CI = 0.63–1.85, p = 0.77; 5 studies), and Hashimoto’s thyroiditis (HT) (pooled RR = 1.56, 95% CI = 0.93–2.60, p = 0.09; 2 studies). Conclusion Our analysis identified that younger age and higher serum TSH levels were higher risk factors for tumor enlargement in low-risk PTMC patients. Pregnancy is a suspected risk factor.Keywords
Funding Information
- National High Level Hospital Clinical Research Funding (2022-PUMCH-B-066, 2022-PUMCH-B-066, 2022-PUMCH-B-066, 2022-PUMCH-B-066)
This publication has 43 references indexed in Scilit:
- Expanded Parameters in Active Surveillance for Low-risk Papillary Thyroid CarcinomaJAMA Oncology, 2022
- Thyroid‐Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low‐Risk Papillary Thyroid Microcarcinoma in AdultsWorld Journal of Surgery, 2022
- Multifocality and Progression of Papillary Thyroid Microcarcinoma During Active SurveillanceWorld Journal of Surgery, 2021
- Association of Patient Age With Progression of Low-risk Papillary Thyroid Carcinoma Under Active SurveillanceJAMA Otolaryngology–Head & Neck Surgery, 2020
- Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active SurveillanceJAMA Otolaryngology–Head & Neck Surgery, 2017
- Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the ThyroidWorld Journal of Surgery, 2016
- The impact of coexistent Hashimoto’s thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinomaTumor Biology, 2015
- Association Between Serum Thyrotropin Concentration and Growth of Asymptomatic Papillary Thyroid MicrocarcinomaWorld Journal of Surgery, 2013
- An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese PatientsWorld Journal of Surgery, 2009
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000